Psychometric properties and measurement equivalence of the English and Chinese versions of the functional assessment of cancer therapy-cognitive in Asian patients with breast cancer
- PMID: 24041350
- DOI: 10.1016/j.jval.2013.06.017
Psychometric properties and measurement equivalence of the English and Chinese versions of the functional assessment of cancer therapy-cognitive in Asian patients with breast cancer
Abstract
Objective: This study was designed to examine the psychometric properties and measurement equivalence of the English and Chinese versions of the Functional Assessment of Cancer Therapy-Cognitive Function (Version 3) (FACT-Cog) in multiethnic Asian patients with breast cancer.
Methods: This prospective study involved patients with breast cancer from the National Cancer Centre Singapore. The concurrent validity of the FACT-Cog was assessed according to its strength of correlation with the validated European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 cognitive functioning scale, and its association with fatigue, global health status, and anxiety. The known-group validity was assessed on the basis of receipt of chemotherapy. Factor analysis was conducted to ascertain the one-factor structure of each cognitive domain. The reliability was evaluated by using Cronbach's alpha and intraclass correlation coefficient within the cognitive domains. Multiple regression analyses were performed to compare the total scores between the two language versions, adjusting for covariates.
Results: A total of 185 English-speaking and 143 Chinese-speaking patients were recruited. Both the English and Chinese FACT-Cog total scores correlated strongly with the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 cognitive functioning scale scores (r = 0.725 and 0.646), whereas correlations with fatigue, anxiety, and global health status were weak to moderate (|r| = 0.376-0.589). Regarding the known-group validity, more severe perceived cognitive disturbance was observed among patients receiving chemotherapy than among those who were not for both versions (P = .010 and .008, respectively). Internal consistencies within the cognitive domains were high (Cronbach's α 0.707-0.929), and test-retest reliability was satisfactory for both versions (intraclass correlation coefficient 0.762 and 0.697). The measurement equivalence between the English and Chinese versions was established for all domains except the multitasking domain.
Conclusion: The English and Chinese versions of the FACT-Cog are valid, reliable, and equivalent for clinical and research use.
Keywords: FACT-Cog; breast cancer; chemobrain; chemofog; chemotherapy; cognitive function; psychooncology; quality of life; validation.
Copyright © 2013, International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.
Similar articles
-
Effects of chemotherapy and psychosocial distress on perceived cognitive disturbances in Asian breast cancer patients.Ann Pharmacother. 2012 Dec;46(12):1645-55. doi: 10.1345/aph.1R408. Epub 2012 Dec 18. Ann Pharmacother. 2012. PMID: 23249868
-
Psychometric properties and measurement equivalence of the English and Chinese versions of the Beck Anxiety Inventory in patients with breast cancer.Support Care Cancer. 2017 Feb;25(2):633-643. doi: 10.1007/s00520-016-3452-3. Epub 2016 Oct 22. Support Care Cancer. 2017. PMID: 27771785
-
Psychometric properties and measurement equivalence of the Multidimensional Fatigue Syndrome Inventory- Short Form (MFSI-SF) amongst breast cancer and lymphoma patients in Singapore.Health Qual Life Outcomes. 2018 Jan 19;16(1):20. doi: 10.1186/s12955-018-0846-6. Health Qual Life Outcomes. 2018. PMID: 29351803 Free PMC article.
-
Predictors of cognitive decline in people with cancer undergoing chemotherapy.Eur J Oncol Nurs. 2017 Apr;27:53-59. doi: 10.1016/j.ejon.2016.12.007. Epub 2016 Dec 24. Eur J Oncol Nurs. 2017. PMID: 28027862 Review.
-
An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors.Support Care Cancer. 2012 Jul;20(7):1361-75. doi: 10.1007/s00520-012-1445-4. Epub 2012 Apr 5. Support Care Cancer. 2012. PMID: 22476439 Review.
Cited by
-
Mental Health, Physical Health, and Cultural Characteristics Among American Indians/Alaska Natives Seeking Substance Use Treatment in an Urban Setting: A Descriptive Study.Community Ment Health J. 2021 Jul;57(5):937-947. doi: 10.1007/s10597-020-00688-3. Epub 2020 Jul 27. Community Ment Health J. 2021. PMID: 32720004 Free PMC article.
-
The Managing Cancer and Living Meaningfully (CALM) Intervention Alleviates Chemotherapy-Related Cognitive Impairment in Patients with Breast Cancer by Modulating Pan-Immune-Inflammation Values.Integr Cancer Ther. 2022 Jan-Dec;21:15347354221140498. doi: 10.1177/15347354221140498. Integr Cancer Ther. 2022. PMID: 36419389 Free PMC article. Clinical Trial.
-
Protocol for the "Chemobrain in Motion - study" (CIM - study): a randomized placebo-controlled trial of the impact of a high-intensity interval endurance training on cancer related cognitive impairments in women with breast cancer receiving first-line chemotherapy.BMC Cancer. 2018 Nov 6;18(1):1071. doi: 10.1186/s12885-018-4992-3. BMC Cancer. 2018. PMID: 30400840 Free PMC article. Clinical Trial.
-
Prechemotherapy Levels of Plasma Dehydroepiandrosterone and Its Sulfated Form as Predictors of Cancer-Related Cognitive Impairment in Patients with Breast Cancer Receiving Chemotherapy.Pharmacotherapy. 2019 May;39(5):553-563. doi: 10.1002/phar.2259. Epub 2019 Apr 4. Pharmacotherapy. 2019. PMID: 30892712 Free PMC article.
-
Managing Cancer and Living Meaningfully (CALM) alleviates chemotherapy related cognitive impairment (CRCI) in breast cancer survivors: A pilot study based on resting-state fMRI.Cancer Med. 2023 Aug;12(15):16231-16242. doi: 10.1002/cam4.6285. Epub 2023 Jul 6. Cancer Med. 2023. PMID: 37409628 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical